C16Y

C16Y is a short peptide and an inhibitor of integrins αvβ3 and α5β1. C16Y acts on the cell membrane and exerts its anticancer activity by inhibiting angiogenesis [1].

Product Specifications

CAS Number

640756-12-3

UNSPSC

12352209

Target

Integrin

Type

Peptides

Related Pathways

Cytoskeleton

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/c16y.html

Smiles

OC(C=C1)=CC=C1C[C@H](NC([C@H](C(C)C)NC([C@H](C)NC([C@@H](NC([C@H](CC(C)C)NC([C@H](CCCCN)NC([C@@H](NC([C@@H](N)CC(O)=O)=O)CC2=CC=CC=C2)=O)=O)=O)CC3=CC=CC=C3)=O)=O)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@H](C(O)=O)CCCNC(N)=N)=O)CC4=CC=C(C=C4)O)=O)=O)=O

Molecular Formula

C78H115N17O17

Molecular Weight

1562.85

References & Citations

[1]Zhou Y, et al. Molecularly Stimuli-Responsive Self-Assembled Peptide Nanoparticles for Targeted Imaging and Therapy. ACS Nano. 2023 May 9;17 (9) :8004-8025.